WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS.

Journal: Arquivos de gastroenterologia

PMID: 30785516

Abstract

BACKGROUND: The infection for the hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality through its evolution to liver cirrhosis, end-stage liver complications and hepatocellular carcinoma. Currently, the new drugs for the HCV infection, based on direct antiviral agents, have changed the outcomes in this setting.

Authors

Giovanni Faria Silva

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Departamento de Clínica Médica, Botucatu, SP, Brasil.
Vanessa Gutierrez de Andrade

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Departamento de Clínica Médica, Botucatu, SP, Brasil.
Alecsandro Moreira

Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Departamento de Clínica Médica, Botucatu, SP, Brasil.

Keywords

Antiviral Agents Female Hepacivirus Hepatitis C, Chronic Humans Incidence Liver Cirrhosis Liver Neoplasms Male Middle Aged Prospective Studies Risk Factors Waiting Lists

External Resources

View on PubMed Access via DOI PubMed (30785516)

WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals